HC Wainwright Trims Cullinan Oncology (NASDAQ:CGEM) Target Price to $28.00

Cullinan Oncology (NASDAQ:CGEM – Free Report) had its price target decreased by HC Wainwright from $29.00 to $28.00 in a research report released on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several other equities analysts have also issued reports on CGEM. Jonestrading lifted their price objective on shares of […]

Related Keywords

United States ,William Blair ,Zurcher Kantonalbank Zurich Cantonalbank ,Stifel Nicolaus ,Jennifer Michaelson ,York Mellon Corp ,Barclays Plc ,Cullinan Oncology Inc ,Cullinan Oncology Company Profile ,Sg Americas Securities ,Cullinan Oncology ,Free Report ,Oncology Trading Down ,Get Free Report ,New York Mellon Corp ,Kantonalbank Zurich Cantonalbank ,Cullinan Oncology Daily ,